BioRestorative Therapies, Inc. ( BRTX) - Key Metrics
BRTX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | ? | ? | ? | ? |
| 2025Q3 | ? | ? | ? | ? |
| 2025Q2 | $0.03 | -$0.30 | -$0.31 | -$0.31 |
| 2025Q1 | $0 | -$0.64 | -$0.33 | -$0.33 |
BRTX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | -2.78% | -1.37 |
| 2025Q1 | -1.93% | -0.70 |
BRTX Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -155.61% | ? |
| 2025Q4 | -23.82% | ? |
| 2025Q3 | -21.95% | ? |
| 2025Q2 | -18.46% | 0.51% |
| 2025Q1 | -18.92% | 0.69% |
BRTX
Price: $0.41
52 week price:
Payout Ratio Range:
Earnings Per Share: -1.06 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 19500
Market Capitalization: 3.6 million